| Jun 5, 2013
| 4:35 PM
Three years after the Food and Drug Administration was taken to task for overlooking safety problems with the diabetes drug Avandia, a panel of FDA advisors met Wednesday to open a two-day review of the research that guided the agency's actions.
| Jun 6, 2013
| 5:06 PM
An advisory panel to the Food and Drug Administration on Thursday voted to keep the diabetes drug Avandia on the market with a slate of restrictions on its use, and suggested that although evidence of the drug's safety problems may have been overblown,...
| Jul 1, 2013
| 4:30 AM
More than a dozen firefighters in Arizona died this weekend, political demonstrations in Brazil were suppressed by more than 10,000 troops, and Egypt is seeing resurgent political demonstrations of its own. Welcome to your post-weekend trends report for...
| Jul 16, 2013
| 4:36 PM
Too much good news in medicine may be bad news for science, according to a new study that suggests animal research is riddled with bias that allows too many treatments to advance to human trials.
Researchers examined data from thousands of experiments...
| Jul 25, 2013
| 11:47 AM
WASHINGTON (Reuters) - Only slightly more than half of U.S. girls aged 13 to 17 had been vaccinated against a virus that can cause cervical and other cancers last year, and a top U.S. health official said on Thursday that more must be done to bring the...
| Jul 25, 2013
| 2:36 PM
July 25 (Reuters) - The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Thursday:
** Dell Inc founder Michael Dell raised his $24.4 billion bid by less than 1 percent just hours before it was to be put to a vote,...
| Jan 13, 2014
As human beings, we are at our best when we can be ourselves, when we live without fear of judgment or the pressures of putting on airs.
As workers, logically, it's no different. An employee living authentically, unencumbered by the distractions of...
| Jan 21, 2014
| 10:32 PM
SAN FRANCISCO — A federal appeals court became the first in the nation to rule that prospective jurors may not be excluded because of their sexual orientation, a decision that expands juror protections beyond race and gender and provides legal...
| Jan 24, 2014
| 3:12 PM
In a decision with wide-reaching implications, a federal appeals court ruled this week that potential jurors cannot be left off of juries based on their sexual orientations.
Remember the antitrust case involving two purveyors of HIV/AIDS drugs that...
| Nov 25, 2013
| 4:52 PM
Avandia, a controversial diabetes drug that was thought to increase patients’ risk of heart attacks and other cardiovascular problems, has been cleared for widespread use by the Food and Drug Administration.
Federal regulators said Monday that the...
| Feb 5, 2014
| 5:11 PM
CVS Caremark Corp.'s imminent exit from the cigarette and tobacco business — an unprecedented move for a major pharmacy company — is being cheered by many medical professionals and lawmakers as a triumph of corporate responsibility over the...